Tesamorelin 12mg Low Dose is a synthetic form of growth hormone-releasing hormone (GHRH) that effectively stimulates the pituitary gland to produce and release growth hormone (GH). Composed of a 44 amino acid sequence, this medication specifically targets GH release, which subsequently increases Insulin-Like Growth Factor-1 (IGF-1) levels in the liver. Originally FDA-approved under the brand name EGRIFTA for treating HIV-associated lipodystrophy, tesamorelin has also been observed for its general health benefits related to increased GH levels.

• Decreased Body Fat: Particularly effective in reducing visceral abdominal fat without affecting subcutaneous fat layers.
• Increased Muscle Mass: Facilitates the growth of lean muscle tissue, enhancing physical strength and body composition.
• Improved Metabolic Functions: Supports better energy utilization and enhances metabolic rate.
• Enhanced Sleep Quality: Contributes to deeper, more restorative sleep and helps combat insomnia.
• Stronger Bone Density: Aids in calcium retention and improves overall bone density.
• Boosted Immune System: Enhances immune functionality, promoting overall health and resistance to illness.
• Improved Skin Health: Increases skin elasticity, aiding in the appearance and health of the skin.
• Tissue Repair: Supports the body's natural repair processes, especially beneficial post-injury.

This lower dose formulation is tailored for individuals seeking the therapeutic benefits of tesamorelin with a reduced intensity of effects, suitable for ongoing management of health conditions and age-related decline.